Fulgent Genetics, Inc. FLGT Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 38.7%-0.1pp | 40.6%+2.7pp | 41.2%+5.0pp | 40%+0.9pp | 38.8%+1.3pp | |
| Operating margin | -33.1%-8.5pp | -28.2%-2.2pp | -22.5%+52.7pp | -24%+41.9pp | -24.6%+42.4pp | |
| Net margin | -23%-9.1pp | -18.8%-3.7pp | -13.6%+45.8pp | -16.8%+39.4pp | -13.9%+43.8pp | |
| EBITDA margin | -25.5%-9.2pp | -20.8%-3.5pp | -14.8%+51.3pp | -16%+41.0pp | -16.3%+41.6pp | |
| Returns | ||||||
| Return on equity | -6.8%-3.2pp | -5.4%-1.6pp | -3.8%+10.0pp | -4.5%+9.1pp | -3.6%+10.2pp | |
| Return on assets | -6.2%-2.9pp | -5%-1.5pp | -3.5%+9.2pp | -4.2%+8.4pp | -3.3%+9.4pp | |
| Return on invested capital | -10.1%-3.4pp | -8.5%-1.5pp | -6.8%+11.6pp | -6.9%+9.8pp | -6.7%+10.1pp | |
| Efficiency | ||||||
| Asset turnover | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.2×0.0× | 0.2×0.0× | |
| Liquidity | ||||||
| Current ratio | 5.3×-1.0× | 6.5×+1.6× | 7×+2.6× | 6×+0.7× | 6.3×+1.2× | |
| Quick ratio | 5.3×-1.0× | 6.5×+1.6× | 7×+2.6× | 6×+0.7× | 6.3×+1.2× | |
| Cash ratio | 0.3×-0.8× | 0.6×-0.2× | 1.6×+0.8× | 1.2×+0.4× | 1×+0.3× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Debt-to-assets | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Per Share | ||||||
| Book value per share | $34.00-7.0% | $36.13-3.6% | $36.62-2.2% | $36.56-2.8% | $36.56-3.7% | |
| Valuation | ||||||
| Market capitalization | $552.11M-7.1% | $812.07M+43.7% | $691.76M+5.1% | $594.26M+1.2% | $521.63M-19.3% | |
| Enterprise value | $536.92M+0.7% | $767.48M+48.7% | $579.68M-4.6% | $511.87M-3.9% | $460.19M-23.6% | |
| Price / sales | 1.7×-0.3× | 2.5×+0.5× | 2.2×-0.2× | 2×-0.1× | 1.8×-0.5× | |
| Price / book | 0.5×0.0× | 0.7×+0.2× | 0.6×0.0× | 0.5×0.0× | 0.5×-0.1× | |
| EV / sales | 1.7×-0.1× | 2.4×+0.6× | 1.8×-0.3× | 1.7×-0.1× | 1.6×-0.5× | |
| Earnings yield | -13.4%-6.5pp | -7.5%+0.1pp | -6.2%+18.8pp | -8.6%+19.2pp | -7.8%+17.9pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Fulgent Genetics, Inc.'s profit margins?
- Fulgent Genetics, Inc. (FLGT) runs a 38.7% gross margin and a -33.1% operating margin, with a -23.0% net margin.
- Where do Fulgent Genetics, Inc.'s ratios come from?
- Every ratio is computed from Fulgent Genetics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
